BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32839254)

  • 1. Oncology workforce skills and competencies required for molecular medicine.
    Groves E
    Eur J Hosp Pharm; 2020 Sep; 27(5):249-250. PubMed ID: 32839254
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining precision medicine.
    Burki TK
    Lancet Oncol; 2017 Dec; 18(12):e719. PubMed ID: 29153736
    [No Abstract]   [Full Text] [Related]  

  • 3. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
    Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
    Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2019 SEOM guidelines (the end of a decade).
    González-Del-Alba A; Rodríguez-Lescure Á
    Clin Transl Oncol; 2020 Feb; 22(2):169-170. PubMed ID: 32030655
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the quality of therapeutic reports of single cases and case series in oncology--criteria and checklist.
    Kienle GS; Hamre HJ; Portalupi E; Kiene H
    Altern Ther Health Med; 2004; 10(5):68-72. PubMed ID: 15478788
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-world data in the molecular era-finding the reality in the real world.
    Dickson DJ; Pfeifer JD
    Clin Pharmacol Ther; 2016 Feb; 99(2):186-97. PubMed ID: 26565654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing access to next-generation sequencing in oncology for Brazil.
    Santos M; Coudry RA; Ferreira CG; Stefani S; Cunha IW; Zalis MG; Araujo LH
    Lancet Oncol; 2019 Jan; 20(1):20-23. PubMed ID: 30614460
    [No Abstract]   [Full Text] [Related]  

  • 9. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 10. National chemotherapy skills passport: a step closer.
    Flynn M
    Br J Nurs; 2012 Feb 23-Mar 7; 21(4):S11. PubMed ID: 22470900
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Tumor Boards in Clinical Practice.
    Luchini C; Lawlor RT; Milella M; Scarpa A
    Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 14. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revalidation and lifelong learning.
    Crellin A
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):657-8. PubMed ID: 21840691
    [No Abstract]   [Full Text] [Related]  

  • 18. Junction Location Identifier (JuLI): Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology.
    Shin HT; Kim NKD; Yun JW; Lee B; Kyung S; Lee KW; Ryu D; Kim J; Bae JS; Park D; Choi YL; Lee SH; Ahn MJ; Park K; Park WY
    J Mol Diagn; 2020 Mar; 22(3):304-318. PubMed ID: 31881333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 20. [The development of competence].
    Hessissen L; Harif M; Crouan A; Martelli H; Patte C; Hatuel R;
    Arch Pediatr; 2015 May; 22(5 Suppl 1):63-4. PubMed ID: 26112524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.